This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Knight, J. A. Articles by Sellers, T. A. Search for Related Content PubMed PubMed Citation Articles by Knight, J. A. Articles by Sellers, T. A.

No Association Between 25-Hydroxyvitamin D and Mammographic Density

¹ Samuel Lunenfeld Research Institute and ² Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada; ³ Mayo Clinic Cancer Center, Rochester, Minnesota; and ⁴ H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida

Requests for reprints: Julia Knight, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 5th Floor, 60 Murray Street, Toronto, Ontario, Canada M5G 1X5. Phone: 416-586-8701; Fax: 416-586-8404. E-mail: knight{at}mshri.on.ca

There is increasing evidence that vitamin D may protect against breast cancer. Some studies have suggested that dietary and supplemental vitamin D is associated with reduced mammographic density, which is highly associated with breast cancer risk, although this evidence is not entirely consistent. We investigated a possible association between circulating 25-hydroxyvitamin D (25OHD), the best indicator of vitamin D status, and quantitative mammographic density in the Minnesota Breast Cancer Family Study. Mean values of mammographic density (both percent and area densities) and circulating levels of 25OHD were compared across categories of covariates using ANOVA. Models were adjusted for age and body mass index, as well as other covariates, and also stratified by dietary calcium intake, menopause, and season. Serum, mammographic density, and questionnaire data were available from 487 women [133 premenopausal and 354 postmenopausal; mean age, 56.4 years (range, 27-85 years)] without breast cancer, and for 73%, the blood was drawn within 1 year of their mammogram. No evidence was found for an association between 25OHD and either percent density or total dense area. There was also no evidence for any association when the data were stratified by season of sample (winter and summer) or menopause. However, both percent density and dense area were lowest among those in the highest vitamin D quartile with calcium intake above the median. Unlike some previous reports, vitamin D does not seem to be related to mammographic density in this cohort. (Cancer Epidemiol Biomarkers Prev 2006;15(10):1988–92)

This article has been cited by other articles:

				D. M. Freedman, S.-C. Chang, R. T. Falk, M. P. Purdue, W.-Y. Huang, C. A. McCarty, B. W. Hollis, B. I. Graubard, C. D. Berg, and R. G. Ziegler Serum Levels of Vitamin D Metabolites and Breast Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 889 - 894. [Abstract] [Full Text] [PDF]

				J. Brisson, S. Berube, C. Diorio, M. Sinotte, M. Pollak, and B. Masse Synchronized Seasonal Variations of Mammographic Breast Density and Plasma 25-Hydroxyvitamin D Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 929 - 933. [Abstract] [Full Text] [PDF]